Reme-D develops diagnostic tests for underserved markets
Reme-D has raised $1.4M in total funding. The most recent round was Seed. The last funding was announced in July 2026.
Reme-D's investors include Anara Impact Capital, Wharton School of the University of Pennsylvania, Mohammed Bin Rashid Innovation Fund (MBRIF), A15, Global Innovation Fund.
Reme-D is headquartered in New York, United States.
Reme-D develops diagnostic tests for underserved markets
Reme-D is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reme-D — Funding & Investors." VCBacked, July 20, 2026, https://www.vcbacked.co/company/reme-d. Accessed August 1, 2026.
VCBacked. (2026). Reme-D — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/reme-d
{{cite web |title=Reme-D — Funding & Investors |url=https://www.vcbacked.co/company/reme-d |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated